| abstract |
The present invention relates to a novel recombinant nanocage and use thereof and to an anticancer agent comprising as an effective ingredient a complex nanocage including a nanocage and an immunogenic apoptosis inducer loaded inside the nanocage, the nanocage being formed by self-assembly of a fusion protein including a phagocytosis-promoting protein and a self-assembling protein. |